Catalyst
Slingshot members are tracking this event:
Valeant's (VRX) Siliq Approved by FDA for Adults with Moderate-to-Severe Plaque Psoriasis
Do you think this event is important to the companies below? How will it affect their stock price?
Additional Information
Slingshot Insights Explained
Catalyst Date
Occurred on:
Feb 16, 2017
Related Projects
-
Don’t see a project related to the catalyst you care about?
Related Keywords
Siliq, Fda, Approval, Adults, Moderate-to-severe, Plaque Psoriasis
